{Reference Type}: Case Reports
{Title}: Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 Expression.
{Author}: Kong BL;Stommel JM;Keck JM;Kilburn D;Streblow A;Egger J;Creason AL;Suciu CG;Guimaraes AR;Corless CL;Mills GB;Pejovic TB;
{Journal}: JCO Precis Oncol
{Volume}: 8
{Issue}: 0
{Year}: 2024 Jun
{Factor}: 5.479
{DOI}: 10.1200/PO.23.00686
{Abstract}: Case report of a HER2-expressed ovarian clear cell carcinoma with exceptional response to trastuzumab deruxtecan.